Foltabs Prenatal (Midlothian Laboratories)
Welcome to the PulseAid listing for the Foltabs Prenatal drug offered from Midlothian Laboratories. This Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Copper [Chemical/Ingredient],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE],Calcium [Chemical/Ingredient],Calcium [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA],Vitamin D [Chemical/Ingredient],Vitamin D [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Midlothian Laboratories |
| NON-PROPRIETARY NAME: | Prenatal Vitamins and Minerals Tablets |
| SUBSTANCE NAME: | POTASSIUM IODIDE; IRON PENTACARBONYL; FERROUS GLUCONATE; DOCUSATE SODIUM; THIAMINE MONONITRATE; RIBOFLAVIN; PYRIDOXINE HYDROCHLORIDE; FOLIC ACID; ZINC OXIDE; CUPRIC OXIDE; ASCORBIC ACID; CALCIUM CITRA |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Copper [Chemical/Ingredient],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE],Calcium [Chemical/Ingredient],Calcium [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA],Vitamin D [Chemical/Ingredient],Vitamin D [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2009-01-01 |
| END MARKETING DATE: | 0000-00-00 |
Foltabs Prenatal HUMAN PRESCRIPTION DRUG Details:
| Item Description | Foltabs Prenatal from Midlothian Laboratories |
| LABELER NAME: | Midlothian Laboratories |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150; 14; 13; 50; 3; 3.4; 30; 1; 25; 2; 120; 125; 20; 30; 400(ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; [iU]/1) |
| START MARKETING DATE: | 2009-01-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68308-165_7d93ca77-68f9-4b29-ac00-8c9a755e7f7c |
| PRODUCT NDC: | 68308-165 |
| APPLICATION NUMBER: | |
Other POTASSIUM IODIDE; IRON PENTACARBONYL; FERROUS GLUCONATE; DOCUSATE SODIUM; THIAMINE MONONITRATE; RIBOFLAVIN; PYRIDOXINE HYDROCHLORIDE; FOLIC ACID; ZINC OXIDE; CUPRIC OXIDE; ASCORBIC ACID; CALCIUM CITRA Pharmaceutical Manufacturers / Labelers:
